Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

NCT05562505 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.

NCT NCT05562505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05562505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Phase
Not applicable
Overall status
Recruiting
Start date
November 28, 2022
Completion date
January 31, 2027
Enrollment
140 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome due to covid-19, covid-19 respiratory infection, extracorporeal membrane oxygenation, hypoxemia, mechanical ventilation complication, pneumonia